FindTrial
Sign In

Neurotrohpin receptor and Alzheimer's Disease

Relationship of?neurotrohpin receptor p75 extracellular domain and Alzheimer's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-12001966
Enrollment
Unknown
Registered
2012-02-26
Start date
2008-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Interventions

Alzheimer's disease group:NA
Mild cognitive impairment group:NA
Age matched healthy individual group:NA

Sponsors

Daping Hospital, the Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 50 to 80 years old; 2. Alzheimer's Disease; according to the ICD-10 diagnostic criteria for Alzheimer's Disease; 3. Mild cognitive impairment; according to the Peterson diagnostic criteria; 4. Age matched healthy individual.

Exclusion criteria

Exclusion criteria: 1. Cerebrovascular disease; 2. Intracranial infection and cerebral trauma; 3. Epilepsia; 4. Demyelinating disease of central nervous system; 5. With severe disease such as heart failure, liver failure, kidney failure and tumour; 6. Other end-stage disease; 7. Psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
Mini-Mental State Examination( MMSE);Montreal Cognitive Assessment (MoCA);imaging detection;p75 neurotrophin receptor extracellular domain;amyloid-beta;tau protein;apolipoprotein E (ApoE);—

Countries

China

Contacts

Public ContactYanjiang Wang
wayaja@gmail.com+86 23 68757852

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026